Biotechnology Stocks II Performance Guide: KalVista Pharmaceuticals, Inc. (KALV)
KALV has no dividends.
Table and Chart of KALV Performance
See what a $1,000 investment in KALV is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| KALV Returns | |
|---|---|
| Start Date | May-29-2015 |
| Start Price | $104.86 |
| End Date | May-16-2024 |
| End Price | $12.07 |
| # Prices | 109 |
| Min Date | Oct-31-2022 |
| Min Price | $5.07 |
| Max Date | May-29-2015 |
| Max Price | $104.86 |
| Total Return | -88.49% |
| Annualized Return | -21.18% |
| Current Value of $1,000 Purchase | $115 |
| Number Returns | 5,886 |
| Average Return | 12.11% |
| Number Profitable Returns | 2,792 |
| Percent Profitable Returns | 47.43% |
| Number Unprofitable Returns | 3,094 |
| Percent Unprofitable Returns | 52.57% |
| Profitable to Unprofitable Returns Ratio | 0.90 |
| KALV Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $506,682,000 |
| Beta | 0.918 | Price to Sales | 107.42 |
| Earnings per Share | $-3.1200 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 5.66 |
| PRICE DATA | |
| 52 Week High | $16.88 |
| 52 Week Low | $7.21 |
| Analyst Target Price | $29.8 |
| 50-Day Moving Average | $11.87 |
| 200-Day Moving Average | $11.1 |
| FINANCIAL DATA | |
| Revenue per Share | $0.214 |
| Revenue | $3,824,000 |
| Profit Margin | 0% |
| Return on Equity | -79.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
KALV Compare Returns with S&P 500
KALV Trendline Chart
KALV Moving Average Chart
KALV Stock Return Map - See Patterns of Gains and Losses
KALV Stock Returns/Purchase Dates